메뉴 건너뛰기




Volumn 74, Issue 2, 2007, Pages 160-167

Treatment of gout;Traitement de la goutte

Author keywords

Allopurinol; Benzbromarone; Colchicine; Diet; Education; Febuxostat; Gout; NSAID; Probenecid; Steroids; Treatment

Indexed keywords


EID: 33847204622     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2006.12.005     Document Type: Short Survey
Times cited : (15)

References (43)
  • 1
    • 33750374233 scopus 로고    scopus 로고
    • EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W., Doherty M., Pascual E., Bardin T., Barskova V., Conaghan P., et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65 (2006) 1301-1311
    • (2006) Ann. Rheum. Dis. , vol.65 , pp. 1301-1311
    • Zhang, W.1    Doherty, M.2    Pascual, E.3    Bardin, T.4    Barskova, V.5    Conaghan, P.6
  • 2
    • 33748608331 scopus 로고    scopus 로고
    • EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W., Doherty M., Bardin T., Pascual E., Barskova V., Conaghan P., et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann. Rheum. Dis. 65 (2006) 1312-1324
    • (2006) Ann. Rheum. Dis. , vol.65 , pp. 1312-1324
    • Zhang, W.1    Doherty, M.2    Bardin, T.3    Pascual, E.4    Barskova, V.5    Conaghan, P.6
  • 3
    • 1942471074 scopus 로고    scopus 로고
    • Alcohol intake and risk of incident gout in men: a prospective study
    • Choi H.K., Atkinson K., Karlson E.W., Willett W., and Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363 (2004) 1277-1281
    • (2004) Lancet , vol.363 , pp. 1277-1281
    • Choi, H.K.1    Atkinson, K.2    Karlson, E.W.3    Willett, W.4    Curhan, G.5
  • 5
    • 12344327218 scopus 로고    scopus 로고
    • Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey
    • Choi H.K., Liu S., and Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 52 (2005) 283-289
    • (2005) Arthritis Rheum. , vol.52 , pp. 283-289
    • Choi, H.K.1    Liu, S.2    Curhan, G.3
  • 6
    • 17644371344 scopus 로고    scopus 로고
    • Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study
    • Choi H.K., Atkinson K., Karlson E.W., and Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch. Intern. Med. 165 (2005) 742-748
    • (2005) Arch. Intern. Med. , vol.165 , pp. 742-748
    • Choi, H.K.1    Atkinson, K.2    Karlson, E.W.3    Curhan, G.4
  • 7
    • 1542316154 scopus 로고    scopus 로고
    • Purine-rich foods, dairy and protein intake, and the risk of gout in men
    • Choi H.K., Atkinson K., Karlson E.W., Willett W., and Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 350 (2004) 1093-1103
    • (2004) N. Engl. J. Med. , vol.350 , pp. 1093-1103
    • Choi, H.K.1    Atkinson, K.2    Karlson, E.W.3    Willett, W.4    Curhan, G.5
  • 8
    • 31544454981 scopus 로고    scopus 로고
    • The prevalence of metabolic syndrome in patients with gout: a multicenter study
    • Rho Y.H., Choi S.J., Lee Y.H., Ji J.D., Choi K.M., Baik S.H., et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J. Korean Med. Sci. 20 (2005) 1029-1033
    • (2005) J. Korean Med. Sci. , vol.20 , pp. 1029-1033
    • Rho, Y.H.1    Choi, S.J.2    Lee, Y.H.3    Ji, J.D.4    Choi, K.M.5    Baik, S.H.6
  • 9
    • 0037809650 scopus 로고    scopus 로고
    • Fenofibrate and losartan
    • Bardin T. Fenofibrate and losartan. Ann. Rheum. Dis. 62 (2003) 497-498
    • (2003) Ann. Rheum. Dis. , vol.62 , pp. 497-498
    • Bardin, T.1
  • 12
    • 33847196892 scopus 로고    scopus 로고
    • Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
    • (in press)
    • Bingham III C.O., Sebba A.I., Rubin B.R., Ruoff G.E., Kremer J., Bird S., et al. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford) (2006) (in press)
    • (2006) Rheumatology (Oxford)
    • Bingham III, C.O.1    Sebba, A.I.2    Rubin, B.R.3    Ruoff, G.E.4    Kremer, J.5    Bird, S.6
  • 14
    • 33845473516 scopus 로고    scopus 로고
    • Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides
    • Schlesinger N. Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. J Clin Rheumatol 12 (2006) 275-276
    • (2006) J Clin Rheumatol , vol.12 , pp. 275-276
    • Schlesinger, N.1
  • 15
    • 0032853025 scopus 로고    scopus 로고
    • Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide
    • Fernandez C., Noguera R., Gonzalez J.A., and Pascual E. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. J. Rheumatol. 26 (1999) 2285-2286
    • (1999) J. Rheumatol. , vol.26 , pp. 2285-2286
    • Fernandez, C.1    Noguera, R.2    Gonzalez, J.A.3    Pascual, E.4
  • 16
    • 0030001513 scopus 로고    scopus 로고
    • Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs
    • Werlen D., Gabay C., and Vischer T.L. Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs. Rev. Rhum. Engl. Ed 63 (1996) 248-254
    • (1996) Rev. Rhum. Engl. Ed , vol.63 , pp. 248-254
    • Werlen, D.1    Gabay, C.2    Vischer, T.L.3
  • 17
    • 0028133477 scopus 로고
    • Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis
    • Siegel L.B., Alloway J.A., and Nashel D.J. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis. J. Rheumatol. 21 (1994) 1325-1327
    • (1994) J. Rheumatol. , vol.21 , pp. 1325-1327
    • Siegel, L.B.1    Alloway, J.A.2    Nashel, D.J.3
  • 18
    • 27144533642 scopus 로고    scopus 로고
    • Allopurinol-induced DRESS syndrome
    • Markel A. Allopurinol-induced DRESS syndrome. Isr. Med. Assoc. J. 7 (2005) 656-660
    • (2005) Isr. Med. Assoc. J. , vol.7 , pp. 656-660
    • Markel, A.1
  • 20
    • 33750428244 scopus 로고    scopus 로고
    • Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients
    • Torres R.J., Prior C., and Puig J.G. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1077-1082
    • (2006) Nucleosides Nucleotides Nucleic Acids , vol.25 , pp. 1077-1082
    • Torres, R.J.1    Prior, C.2    Puig, J.G.3
  • 21
    • 17644375873 scopus 로고    scopus 로고
    • Clinical heterogeneity of drug hypersensitivity
    • Roujeau J.C. Clinical heterogeneity of drug hypersensitivity. Toxicology 209 (2005) 123-129
    • (2005) Toxicology , vol.209 , pp. 123-129
    • Roujeau, J.C.1
  • 22
    • 0031662935 scopus 로고    scopus 로고
    • Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout
    • Perez-Ruiz F., Alonso-Ruiz A., Calabozo M., Herrero-Beites A., Garcia-Erauskin G., and Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann. Rheum. Dis. 57 (1998) 545-549
    • (1998) Ann. Rheum. Dis. , vol.57 , pp. 545-549
    • Perez-Ruiz, F.1    Alonso-Ruiz, A.2    Calabozo, M.3    Herrero-Beites, A.4    Garcia-Erauskin, G.5    Ruiz-Lucea, E.6
  • 23
    • 0033668058 scopus 로고    scopus 로고
    • Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts
    • Perez-Ruiz F., Calabozo M., Herrero-Beites A.M., Garcia-Erauskin G., and Pijoan J.I. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86 (2000) 287-291
    • (2000) Nephron , vol.86 , pp. 287-291
    • Perez-Ruiz, F.1    Calabozo, M.2    Herrero-Beites, A.M.3    Garcia-Erauskin, G.4    Pijoan, J.I.5
  • 24
    • 33847187129 scopus 로고
    • Probenecid (benemid): its uses and side-effects in 2,502 patients
    • Boger W.P., and Strickland S.C. Probenecid (benemid): its uses and side-effects in 2,502 patients. AMA Arch. Intern. Med. 95 (1955) 83-92
    • (1955) AMA Arch. Intern. Med. , vol.95 , pp. 83-92
    • Boger, W.P.1    Strickland, S.C.2
  • 25
    • 0017720265 scopus 로고
    • Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia
    • Heel R.C., Brogden R.N., Speight T.M., and Avery G.S. Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia. Drugs 14 (1977) 349-366
    • (1977) Drugs , vol.14 , pp. 349-366
    • Heel, R.C.1    Brogden, R.N.2    Speight, T.M.3    Avery, G.S.4
  • 26
    • 0019501056 scopus 로고
    • Ten years' experience with benzbromarone in the management of gout and hyperuricaemia
    • Masbernard A., and Giudicelli C.P. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia. S. Afr. Med. J. 59 (1981) 701-706
    • (1981) S. Afr. Med. J. , vol.59 , pp. 701-706
    • Masbernard, A.1    Giudicelli, C.P.2
  • 27
    • 26944437126 scopus 로고    scopus 로고
    • Benzbromarone therapy in management of refractory gout
    • Kumar S., Ng J., and Gow P. Benzbromarone therapy in management of refractory gout. N. Z. Med. J. 118 (2005) U1528
    • (2005) N. Z. Med. J. , vol.118
    • Kumar, S.1    Ng, J.2    Gow, P.3
  • 28
    • 0016929629 scopus 로고
    • Clinical evaluation of benzbromarone: a new uricosuric drug
    • Sorensen L.B., and Levinson D.J. Clinical evaluation of benzbromarone: a new uricosuric drug. Arthritis Rheum. 19 (1976) 183-190
    • (1976) Arthritis Rheum. , vol.19 , pp. 183-190
    • Sorensen, L.B.1    Levinson, D.J.2
  • 29
    • 85047698010 scopus 로고
    • Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study
    • Zurcher R.M., Bock H.A., and Thiel G. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study. Nephrol. Dial. Transplant. 9 (1994) 548-551
    • (1994) Nephrol. Dial. Transplant. , vol.9 , pp. 548-551
    • Zurcher, R.M.1    Bock, H.A.2    Thiel, G.3
  • 30
    • 33744963408 scopus 로고    scopus 로고
    • Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol
    • (quiz 343)
    • Richette P., and Bardin T. Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol. Nat. Clin. Pract. Rheumatol. 2 (2006) 338-342 (quiz 343)
    • (2006) Nat. Clin. Pract. Rheumatol. , vol.2 , pp. 338-342
    • Richette, P.1    Bardin, T.2
  • 31
    • 30744449541 scopus 로고    scopus 로고
    • Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases
    • Ka T., Inokuchi T., Tsutsumi Z., Takahashi S., Moriwaki Y., and Yamamoto T. Effects of a fenofibrate/losartan combination on the plasma concentration and urinary excretion of purine bases. Int. J. Clin. Pharmacol. Ther. 44 (2006) 22-26
    • (2006) Int. J. Clin. Pharmacol. Ther. , vol.44 , pp. 22-26
    • Ka, T.1    Inokuchi, T.2    Tsutsumi, Z.3    Takahashi, S.4    Moriwaki, Y.5    Yamamoto, T.6
  • 32
    • 0023905821 scopus 로고
    • Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial
    • Bastow M.D., Durrington P.N., and Ishola M. Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial. Metabolism 37 (1988) 217-220
    • (1988) Metabolism , vol.37 , pp. 217-220
    • Bastow, M.D.1    Durrington, P.N.2    Ishola, M.3
  • 33
    • 33748415886 scopus 로고    scopus 로고
    • Effect of fenofibrate in combination with urate lowering agents in patients with gout
    • Lee Y.H., Lee C.H., and Lee J. Effect of fenofibrate in combination with urate lowering agents in patients with gout. Korean J. Intern. Med. 21 (2006) 89-93
    • (2006) Korean J. Intern. Med. , vol.21 , pp. 89-93
    • Lee, Y.H.1    Lee, C.H.2    Lee, J.3
  • 34
    • 0038325699 scopus 로고    scopus 로고
    • Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism
    • Takahashi S., Moriwaki Y., Yamamoto T., Tsutsumi Z., Ka T., and Fukuchi M. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism. Ann. Rheum. Dis. 62 (2003) 572-575
    • (2003) Ann. Rheum. Dis. , vol.62 , pp. 572-575
    • Takahashi, S.1    Moriwaki, Y.2    Yamamoto, T.3    Tsutsumi, Z.4    Ka, T.5    Fukuchi, M.6
  • 35
    • 0042073189 scopus 로고    scopus 로고
    • Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis
    • Perez-Ruiz F., and Nolla J.M. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis. J Clin Rheumatol 9 (2003) 215-218
    • (2003) J Clin Rheumatol , vol.9 , pp. 215-218
    • Perez-Ruiz, F.1    Nolla, J.M.2
  • 36
    • 14944345365 scopus 로고    scopus 로고
    • Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout
    • Becker M.A., Schumacher Jr. H.R., Wortmann R.L., MacDonald P.A., Palo W.A., Eustace D., et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum. 52 (2005) 916-923
    • (2005) Arthritis Rheum. , vol.52 , pp. 916-923
    • Becker, M.A.1    Schumacher Jr., H.R.2    Wortmann, R.L.3    MacDonald, P.A.4    Palo, W.A.5    Eustace, D.6
  • 38
    • 17144396355 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment
    • Mayer M.D., Khosravan R., Vernillet L., Wu J.T., Joseph-Ridge N., and Mulford D.J. Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment. Am. J. Ther. 12 (2005) 22-34
    • (2005) Am. J. Ther. , vol.12 , pp. 22-34
    • Mayer, M.D.1    Khosravan, R.2    Vernillet, L.3    Wu, J.T.4    Joseph-Ridge, N.5    Mulford, D.J.6
  • 39
    • 29644447615 scopus 로고    scopus 로고
    • The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
    • Khosravan R., Grabowski B.A., Mayer M.D., Wu J.T., Joseph-Ridge N., and Vernillet L. The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase. J. Clin. Pharmacol. 46 (2006) 88-102
    • (2006) J. Clin. Pharmacol. , vol.46 , pp. 88-102
    • Khosravan, R.1    Grabowski, B.A.2    Mayer, M.D.3    Wu, J.T.4    Joseph-Ridge, N.5    Vernillet, L.6
  • 40
    • 33746995205 scopus 로고    scopus 로고
    • Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
    • Ganson N.J., Kelly S.J., Scarlett E., Sundy J.S., and Hershfield M.S. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase. Arthritis Res. Ther. 8 (2006) R12
    • (2006) Arthritis Res. Ther. , vol.8
    • Ganson, N.J.1    Kelly, S.J.2    Scarlett, E.3    Sundy, J.S.4    Hershfield, M.S.5
  • 41
    • 10044275104 scopus 로고    scopus 로고
    • Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis
    • Borstad G.C., Bryant L.R., Abel M.P., Scroggie D.A., Harris M.D., and Alloway J.A. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J. Rheumatol. 31 (2004) 2429-2432
    • (2004) J. Rheumatol. , vol.31 , pp. 2429-2432
    • Borstad, G.C.1    Bryant, L.R.2    Abel, M.P.3    Scroggie, D.A.4    Harris, M.D.5    Alloway, J.A.6
  • 42
    • 33750022818 scopus 로고    scopus 로고
    • The management of gout at an academic healthcare center in Beijing: a physician survey
    • Fang W., Zeng X., Li M., Chen L.X., Schumacher Jr. H.R., and Zhang F. The management of gout at an academic healthcare center in Beijing: a physician survey. J. Rheumatol. 33 (2006) 2041-2049
    • (2006) J. Rheumatol. , vol.33 , pp. 2041-2049
    • Fang, W.1    Zeng, X.2    Li, M.3    Chen, L.X.4    Schumacher Jr., H.R.5    Zhang, F.6
  • 43
    • 33745610176 scopus 로고    scopus 로고
    • Gout medication treatment patterns and adherence to standards of care from a managed care perspective
    • Sarawate C.A., Brewer K.K., Yang W., Patel P.A., Schumacher H.R., Saag K.G., et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin. Proc. 81 (2006) 925-934
    • (2006) Mayo Clin. Proc. , vol.81 , pp. 925-934
    • Sarawate, C.A.1    Brewer, K.K.2    Yang, W.3    Patel, P.A.4    Schumacher, H.R.5    Saag, K.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.